PharmStars is the pharma-focused accelerator for digital health startups, dedicated to driving digital health adoption to improve patient outcomes. We educate and mentor digital health startups seeking engagement with pharma and biotech firms. We are supported by our pharma members who are committed to working with startups that graduate from our accelerator.
Digital health has the potential to transform the pharmaceutical industry and the patient experience. Digital health and pharma firms are eager to engage with one another. Yet both have found it challenging to create successful partnerships.
PharmStars is a novel digital health accelerator aimed at bridging the pharma-startup gap to drive greater adoption of digital health. Our 10-week accelerator program is designed to prepare startups for more productive engagements with pharma by teaching them what they need to know. The program culminates with the Showcase Event. Startups present their solutions to our pharma members and then have the opportunity to meet individually with them.
"Our mission is to facilitate and accelerate successful partnerships between digital health startups and pharma, leading to greater success for each and faster adoption of digital health to improve patient outcomes."
- Naomi Fried PhD, Founder & CEO, PharmStars
Our next cohort is about to launch! Digital health startups, with market-ready solutions in our theme area and interested in engaging with pharma, are encouraged to apply. Please refer to our Program Terms for the detailed requirements.
The centerpiece of the PharmStars accelerator is PharmaU: a unique, comprehensive educational program. Its three components are a curriculum for startups, mentoring for startups, and "Executive Ed" courses for pharma. PharmaU’s courses are developed and led by PharmStars’ experienced team of former pharma executives with deep expertise in digital health, innovation, and startups.
Individualized coaching from our PharmStars staff on how startups can successfully engage pharma. We guide startups through the process, from building a compelling value proposition through crafting an effective pitch.
Workshops and seminars for pharma members, providing insight into how to successfully implement digital health programs and partnerships.
March 21- May 26
June (date TBD)
Neurological diseases are the number one cause of long-term disability and the second leading cause of death worldwide1,2. Despite pharmacological advances and a growing understanding of complex neurological disease, tremendous opportunity exists to improve all aspects of neurological disease management including the patient journey, drug development, and caregiver burden. This PharmStars cohort will focus on startups with digital innovations for neurological diseases, spanning multiple neurological conditions (including but not limited to Alzheimer’s, Parkinson’s, ALS, pain, depression, etc.) and presenting many opportunities including:
Digital health startups with a product or prototype in this space are invited to apply by the application deadline: February 4, 2021. Please refer to the Program Terms for full program requirements.